|
|
Progesterone |
Systematic (IUPAC) name |
Pregn-4-ene-3,20-dione |
Identifiers |
CAS number | 57-83-0 |
ATC code | G03DA04 |
PubChem | 5994 |
DrugBank | DB00396 |
ChemSpider | 5773 |
Chemical data |
Formula | C21H30Template:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxO2Template:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBox |
Mol. mass | 314.46 |
SMILES | eMolecules & PubChem |
Synonyms | 4-pregnene-3,20-dione |
Physical data |
Melt. point | 126 °C (259 °F) |
Spec. rot | [α]D |
Pharmacokinetic data |
Bioavailability | prolonged absorption, half-life approx 25-50 hours |
Protein binding | 96%-99% |
Metabolism | hepatic to pregnanediols and pregnanolones |
Half life | 34.8-55.13 hours |
Excretion | renal |
Therapeutic considerations |
Pregnancy cat. | B (USA) |
Legal status | |
Routes | oral, implant, transdermal |